SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-241987
Filing Date
2019-09-10
Accepted
2019-09-10 16:06:03
Documents
14
Period of Report
2019-09-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d801823d8k.htm   iXBRL 8-K 27773
2 EX-99.1 d801823dex991.htm EX-99.1 15493
6 GRAPHIC g801823g0910205237316.jpg GRAPHIC 2435
  Complete submission text file 0001193125-19-241987.txt   171934

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA myok-20190910.xsd EX-101.SCH 3073
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20190910_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20190910_pre.xml EX-101.PRE 10955
11 EXTRACTED XBRL INSTANCE DOCUMENT d801823d8k_htm.xml XML 3254
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 191085397
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1